comparemela.com

Latest Breaking News On - Abbvie biotherapeutics - Page 1 : comparemela.com

Elotuzumab Plus Pomalidomide and Dexamethasone Improves Survival in Relapsed/Refractory Multiple Myeloma

Researchers determined elotuzumab with pomalidomide and dexamethasone improved overall survival in patients with relapsed/refractory multiple myeloma.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.